Study results indicate that patients treated with Spineart’s BAGUERA® C cervical disc in 1- or 2-level arthroplasty exhibited good mobility at treated and adjacent levels, disc height restoration and evidence of adjacent level preservation.
Cartiva received FDA Premarket Approval for the Synthetic Cartilage Implant to treat arthritis of the great toe. Product introduction will occur within 7/16.
Prosidyan entered into a joint collaboration and license agreement with MO-SCI Corporation for a technology using boron-based bioactive glass materials for applications in spine and trauma.
The Stephens Group, a private investment firm, announced that it finalized its partnership with CoreLink. Terms of the transaction were not disclosed.